Geoffrey Raymond Oxnard insider trades

Open-market stock purchases and sales by Geoffrey Raymond Oxnard, Chief Medical Officer at BlossomHill Therapeutics, Inc, from SEC Form 4 filings since Aug 6, 2026.

Recent trades

DateStockTradeValue
Aug 6, 2026BLSM BlossomHill Therapeutics, IncBought (not open market)—

Companies traded

  • BLSM BlossomHill Therapeutics, Inc: other filings, last Aug 6, 2026

Get free alerts when Geoffrey Raymond Oxnard files a new trade →